Roivant Sciences Ltd. (ROIV) insider trading.
In Q3 2026, insiders at Roivant Sciences Ltd. reported 51 non-derivative transactions on 30 Forms 3, 4 and 5: 0 open-market purchases and 18 sales worth $52.8M.
- Transactions
- 51
- Purchases (P)
- 0
- Sales (S)
- 18
- Net shares, P minus S
- -1,457,800
- Insiders
- 12
- Last filed
- 2026-09-22
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Sukhatme Mayukh | Director, Officer · President & CIO | 15 | 0 | 7 |
| Fitzgerald Meghan | Director | 8 | 0 | 4 |
| Epperly Melissa B, | Director | 8 | 0 | 4 |
| Venker Eric | Officer · President & Immunovant CEO | 6 | 0 | 3 |
| Momtazee James C | Director | 3 | 0 | 0 |
| Oren Ilan | Director | 3 | 0 | 0 |
| Pulik Richard | Officer · CFO | 2 | 0 | 0 |
| Gold Daniel Allen | Director | 2 | 0 | 0 |
| Humes Jennifer | Officer · Chief Accounting Officer | 1 | 0 | 0 |
| Manchester Keith S | Director | 1 | 0 | 0 |
| Torti Frank | Officer · President and Vant Chair | 1 | 0 | 0 |
| Gline Matthew | Director, Officer · CEO | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-20 | Humes Jennifer | F (D) | 3,880 | $39.77 | 106,419 | Form 4 |
| 2026-09-20 | Pulik Richard | F (D) | 2,129 | $39.77 | 269,681 | Form 4 |
| 2026-09-16 | Manchester Keith S | A (A) | 5,054 | $0 | 1,753,457 | Form 4 |
| 2026-09-16 | Momtazee James C | A (A) | 5,054 | $0 | 111,959 | Form 4 |
| 2026-09-16 | Fitzgerald Meghan | A (A) | 5,054 | $0 | 41,162 | Form 4 |
| 2026-09-16 | Oren Ilan | A (A) | 5,054 | $0 | 123,680 | Form 4 |
| 2026-09-16 | Gold Daniel Allen | A (A) | 5,054 | $0 | 8,965,815 | Form 4 |
| 2026-09-16 | Epperly Melissa B, | A (A) | 5,054 | $0 | 14,954 | Form 4 |
| 2026-09-15 | Fitzgerald Meghan | S (D) | 400 | $40.45 | 36,108 | Form 4 |
| 2026-09-15 | Fitzgerald Meghan | S (D) | 4,712 | $39.68 | 36,508 | Form 4 |
| 2026-09-15 | Epperly Melissa B, | S (D) | 4,338 | $39.65 | 10,500 | Form 4 |
| 2026-09-15 | Epperly Melissa B, | S (D) | 600 | $40.38 | 9,900 | Form 4 |
| 2026-09-10 | Gold Daniel Allen | F (D) | 5,133 | $40.94 | 8,960,761 | Form 4 |
| 2026-09-10 | Momtazee James C | F (D) | 2,905 | $40.94 | 106,905 | Form 4 |
| 2026-09-10 | Fitzgerald Meghan | F (D) | 1,743 | $40.94 | 41,220 | Form 4 |
| 2026-09-10 | Oren Ilan | F (D) | 2,378 | $40.94 | 118,626 | Form 4 |
| 2026-09-10 | Epperly Melissa B, | F (D) | 2,179 | $40.94 | 14,838 | Form 4 |
| 2026-09-08 | Fitzgerald Meghan | S (D) | 20,000 | $39.9 | 42,963 | Form 4 |
| 2026-09-08 | Fitzgerald Meghan | M (A) | 20,000 | $8.8 | 62,963 | Form 4 |
| 2026-08-28 | Venker Eric | S (D) | 166,182 | $35.63 | 1,632,972 | Form 4 |
| 2026-08-28 | Venker Eric | M (A) | 200,000 | $3.85 | 1,799,154 | Form 4 |
| 2026-08-28 | Venker Eric | S (D) | 33,818 | $36.44 | 1,599,154 | Form 4 |
| 2026-08-21 | Sukhatme Mayukh | S (D) | 144,756 | $36.48 | 18,630,739 | Form 4 |
| 2026-08-21 | Sukhatme Mayukh | M (A) | 144,756 | $3.85 | 18,775,495 | Form 4 |
| 2026-08-20 | Venker Eric | F (D) | 13,909 | $36.84 | 1,599,154 | Form 4 |
| 2026-08-20 | Pulik Richard | F (D) | 5,749 | $36.84 | 271,810 | Form 4 |
| 2026-08-20 | Sukhatme Mayukh | S (D) | 17,519 | $37.3 | 18,630,739 | Form 4 |
| 2026-08-20 | Sukhatme Mayukh | M (A) | 17,519 | $3.85 | 18,648,258 | Form 4 |
| 2026-08-19 | Sukhatme Mayukh | S (D) | 172,899 | $37.17 | 18,630,739 | Form 4 |
| 2026-08-19 | Sukhatme Mayukh | M (A) | 172,899 | $3.85 | 18,803,638 | Form 4 |
| 2026-08-18 | Sukhatme Mayukh | M (A) | 105,141 | $3.85 | 18,735,880 | Form 4 |
| 2026-08-18 | Sukhatme Mayukh | S (D) | 105,141 | $36.59 | 18,630,739 | Form 4 |
| 2026-08-18 | Sukhatme Mayukh | M (A) | 31,801 | $3.85 | 18,662,540 | Form 4 |
| 2026-08-18 | Sukhatme Mayukh | S (D) | 31,801 | $37.18 | 18,630,739 | Form 4 |
| 2026-08-17 | Sukhatme Mayukh | M (A) | 284,707 | $3.85 | 18,915,446 | Form 4 |
| 2026-08-17 | Sukhatme Mayukh | S (D) | 284,707 | $36.25 | 18,630,739 | Form 4 |
| 2026-08-14 | Sukhatme Mayukh | S (D) | 243,177 | $36.23 | 18,630,739 | Form 4 |
| 2026-08-14 | Sukhatme Mayukh | M (A) | 243,177 | $3.85 | 18,873,916 | Form 4 |
| 2026-07-27 | Venker Eric | S (D) | 200,000 | $34.95 | 1,613,063 | Form 4 |
| 2026-07-27 | Venker Eric | M (A) | 200,000 | $3.85 | 1,813,063 | Form 4 |
| 2026-07-17 | Oren Ilan | A (A) | 775 | $0 | 121,004 | Form 4 |
| 2026-07-17 | Epperly Melissa B, | A (A) | 543 | $0 | 17,017 | Form 4 |
| 2026-07-17 | Momtazee James C | A (A) | 405 | $0 | 109,810 | Form 4 |
| 2026-06-30 | Fitzgerald Meghan | M (A) | 10,000 | $8.8 | 52,963 | Form 4 |
| 2026-06-30 | Fitzgerald Meghan | S (D) | 10,000 | $34.9 | 42,963 | Form 4 |
| 2026-06-30 | Sukhatme Mayukh | F (D) | 46,878 | $35.39 | 18,630,739 | Form 4 |
| 2026-06-30 | Torti Frank | F (D) | 40,310 | $35.39 | 13,536,202 | Form 4 |
| 2026-06-30 | Gline Matthew | F (D) | 76,171 | $35.39 | 16,659,945 | Form 4 |
| 2026-06-29 | Epperly Melissa B, | M (A) | 17,750 | $4.46 | 34,224 | Form 4 |
| 2026-06-29 | Epperly Melissa B, | S (D) | 2,748 | $34.71 | 16,474 | Form 4 |
| 2026-06-29 | Epperly Melissa B, | S (D) | 15,002 | $34.32 | 19,222 | Form 4 |
Transaction codes in this quarter
Get ROIV insider transactions through the API
Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1635088&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ROIV company page · Roivant Sciences Ltd. on SEC.gov
Questions
Are insiders buying or selling Roivant Sciences Ltd. (ROIV)?
In Q3 2026, insiders at Roivant Sciences Ltd. reported 51 non-derivative transactions on 30 Forms 3, 4 and 5: 0 open-market purchases and 18 sales worth $52.8M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Roivant Sciences Ltd. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.
Plain-text version for agents and LLMs: /insider-trading/roiv.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.